Top Cancer Stocks in Japan
Browse the largest Japan companies in the world ranked by their Market Capitalization. Global Cancer Companies in Japan market cap is $571.08M.
25 Aug 2024, 14:20 UTC
Companies: 9
🇯🇵1 | $3.67 | 7.07% | 106.00M | 89.29% | Outperform S&P500 YTD Benchamark | 💊 Pharma | - | |
🇯🇵2 | $5.12 | 15.65% | 76.69M | -22.86% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇯🇵3 | $0.35 | -3.77% | 68.05M | 121.74% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇯🇵4 | $0.38 | 1.85% | 64.11M | 19.57% | Outperform S&P500 YTD Benchamark | 💊 Pharma | - | |
🇯🇵5 | $5.30 | 3.94% | 62.31M | 23.39% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇯🇵6 | $1.36 | -2.97% | 58.75M | -5.31% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇯🇵7 | $2.81 | -0.25% | 48.21M | -20.70% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇯🇵8 | $0.40 | 0.00% | 23.97M | -32.56% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇯🇵9 | $4.18 | -1.31% | 23.66M | -39.21% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |